Return On Equity of NEVRO CORP from 30 Jun 2015 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NEVRO CORP quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 31 Dec 2024.
  • NEVRO CORP Return On Equity for the quarter ending 31 Dec 2024 was -43%, a 37% decline year-over-year.
  • NEVRO CORP annual Return On Equity for 2024 was -43%, a 37% decline from 2023.
  • NEVRO CORP annual Return On Equity for 2023 was -31%, a 3027% decline from 2022.
  • NEVRO CORP annual Return On Equity for 2022 was 1.1%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NEVRO CORP Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -43% -12% -37% 01 Oct 2024 31 Dec 2024
Q3 2024 -25% +9.2% +27% 01 Jul 2024 30 Sep 2024
Q2 2024 -27% -28% -3424% 01 Apr 2024 30 Jun 2024
Q1 2024 -29% -29% -3782% 01 Jan 2024 31 Mar 2024
Q4 2023 -31% -32% -3027% 01 Oct 2023 31 Dec 2023
Q3 2023 -34% -31% -1076% 01 Jul 2023 30 Sep 2023
Q2 2023 0.82% +52% 01 Apr 2023 30 Jun 2023
Q1 2023 0.78% +45% 01 Jan 2023 31 Mar 2023
Q4 2022 1.1% +40% 01 Oct 2022 31 Dec 2022
Q3 2022 -2.9% +27% +90% 01 Jul 2022 30 Sep 2022
Q2 2022 -51% -33% -179% 01 Apr 2022 30 Jun 2022
Q1 2022 -45% -21% -92% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% -15% -59% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% -0.01% -0.03% 01 Jul 2021 30 Sep 2021
Q2 2021 -18% +21% +53% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +17% +43% 01 Jan 2021 31 Mar 2021
Q4 2020 -24% +25% +51% 01 Oct 2020 31 Dec 2020
Q3 2020 -30% +16% +35% 01 Jul 2020 30 Sep 2020
Q2 2020 -39% +2.2% +5.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -41% -8.8% -28% 01 Jan 2020 31 Mar 2020
Q4 2019 -50% -30% -148% 01 Oct 2019 31 Dec 2019
Q3 2019 -46% -28% -159% 01 Jul 2019 30 Sep 2019
Q2 2019 -41% -25% -159% 01 Apr 2019 30 Jun 2019
Q1 2019 -32% -16% -95% 01 Jan 2019 31 Mar 2019
Q4 2018 -20% -5.1% -34% 01 Oct 2018 31 Dec 2018
Q3 2018 -18% -0.62% -3.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -16% +0.41% +2.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -16% -1.3% -8.7% 01 Jan 2018 31 Mar 2018
Q4 2017 -15% -1.9% -15% 01 Oct 2017 31 Dec 2017
Q3 2017 -17% -2.2% -14% 01 Jul 2017 30 Sep 2017
Q2 2017 -16% +5.4% +25% 01 Apr 2017 30 Jun 2017
Q1 2017 -15% +11% +42% 01 Jan 2017 31 Mar 2017
Q4 2016 -13% +17% +56% 01 Oct 2016 31 Dec 2016
Q3 2016 -15% +14% +49% 01 Jul 2016 30 Sep 2016
Q2 2016 -22% +19% +47% 01 Apr 2016 30 Jun 2016
Q1 2016 -26% 01 Jan 2016 31 Mar 2016
Q4 2015 -30% 01 Oct 2015 31 Dec 2015
Q3 2015 -29% 01 Jul 2015 30 Sep 2015
Q2 2015 -41% 01 Apr 2015 30 Jun 2015

NEVRO CORP Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -43% -12% -37% 01 Jan 2024 31 Dec 2024
2023 -31% -32% -3027% 01 Jan 2023 31 Dec 2023
2022 1.1% +40% 01 Jan 2022 31 Dec 2022
2021 -39% -15% -59% 01 Jan 2021 31 Dec 2021
2020 -24% +25% +51% 01 Jan 2020 31 Dec 2020
2019 -50% -30% -148% 01 Jan 2019 31 Dec 2019
2018 -20% -5.1% -34% 01 Jan 2018 31 Dec 2018
2017 -15% -1.9% -15% 01 Jan 2017 31 Dec 2017
2016 -13% +17% +56% 01 Jan 2016 31 Dec 2016
2015 -30% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.